ATE394114T1 - Somatostatin-antagonisten - Google Patents

Somatostatin-antagonisten

Info

Publication number: ATE394114T1
Authority: AT; Austria
Prior art keywords: somatostatin antagonists; somatostatin; antagonists
Prior art date: 2001-03-08

Application number

AT02728410T

Other languages

English (en)

Inventor

David Coy

William Murphy

Walajapet Rajeswaran

Original Assignee

Univ Tulane

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-08

Filing date

2002-03-05

Publication date

2008-05-15

2002-03-05 Application filed by Univ Tulane filed Critical Univ Tulane

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE394114T1 publication Critical patent/ATE394114T1/de

Links

102000005157 Somatostatin Human genes 0.000 title 1
108010056088 Somatostatin Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229960000553 somatostatin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Obesity (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT02728410T 2001-03-08 2002-03-05 Somatostatin-antagonisten ATE394114T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US27430801P	2001-03-08	2001-03-08

Publications (1)

Publication Number	Publication Date
ATE394114T1 true ATE394114T1 (de)	2008-05-15

Family

ID=23047655

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02728410T ATE394114T1 (de)	2001-03-08	2002-03-05	Somatostatin-antagonisten

Country Status (16)

Country	Link
US (3)	US7378488B2 (de)
EP (1)	EP1372688B1 (de)
JP (3)	JP4204322B2 (de)
AR (1)	AR035942A1 (de)
AT (1)	ATE394114T1 (de)
AU (1)	AU2002258465B2 (de)
CA (1)	CA2439498A1 (de)
CZ (1)	CZ299362B6 (de)
DE (1)	DE60226419D1 (de)
DK (1)	DK1372688T3 (de)
ES (1)	ES2306766T3 (de)
HU (1)	HUP0401535A3 (de)
NO (1)	NO20033911L (de)
PL (1)	PL362838A1 (de)
RU (2)	RU2263678C2 (de)
WO (1)	WO2002072602A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3290302A (en) *	2000-10-20	2002-04-29	Univ Tulane	Urotensin-ii agonists and antagonists
RU2263678C2 (ru)	2001-03-08	2005-11-10	Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд	Антагонисты соматостатина
JP2004531520A (ja) *	2001-04-09	2004-10-14	ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド	ソマトスタチンアゴニスト
EP1522311A1 (de) *	2003-10-10	2005-04-13	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Verwendung von Somatostatin oder seine Derivate zur Herstellung eines Medikamentes zur Regulierung der Ovarialfollikelnreserve bei der nicht menopausierte Frau
US8017575B2 (en) *	2004-12-15	2011-09-13	Wilfred Wayne Lautt	Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
PL2383289T3 (pl) *	2006-10-16	2015-03-31	Salk Inst Biological Studies	Antagoniści somatostatyny selektywni względem receptora (SSTR2)
US8691761B2 (en) *	2006-10-16	2014-04-08	Jean E. F. Rivier	Somatostatin receptor 2 antagonists
EP2168983A1 (de)	2008-09-30	2010-03-31	Ipsen Pharma	Neue Oktapeptid-Verbindungen und ihr therapeutischer Einsatz
SG10201400650QA (en)	2008-10-29	2014-05-29	Kaneka Corp	Method For Producing L-Amino Acid
EP2399931A1 (de) *	2010-06-22	2011-12-28	Ipsen Pharma S.A.S.	Neue Oktapeptid-Verbindungen und ihr therapeutischer Einsatz
US11279732B2 (en)	2016-02-09	2022-03-22	Cdrd Ventures Inc.	Somatostatin receptor antagonist compounds and methods of using the same
WO2021111503A1 (ja) *	2019-12-02	2021-06-10	花王株式会社	光吸収層及びその製造方法、分散液、光電変換素子、並びに太陽電池

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0034567B1 (de) *	1980-02-14	1984-11-07	Sandoz Ag	Verfahren zur Totalsynthese von Cyclosporinen und neue Cyclosporine
JPS63146850A (ja)	1986-11-12	1988-06-18	メルク　エンド　カムパニー　インコーポレーテツド	フエニルアラニル−ヒスチジン代用成分を有するレニン阻害剤
EP0278158A3 (de)	1986-11-12	1990-05-23	Merck & Co. Inc.	Renin-Inhibitoren enthaltende Phenylalanin-Histidin-Stellvertreter
EP0273696A2 (de)	1987-01-02	1988-07-06	Merck & Co. Inc.	Renin-Inhibitoren, in denen Histidin ersetzt ist
CH679045A5 (de)	1987-06-29	1991-12-13	Sandoz Ag
JPS6426599U (de)	1987-08-10	1989-02-15
DE68928278T2 (de)	1988-02-10	1998-03-12	Tap Pharmaceuticals Inc	Lhrh-analog
ES2091907T3 (es) *	1989-12-08	1996-11-16	Univ Tulane	Analogos octapeptidos de somatostina con una threonina en la sexta posicion.
US7223833B1 (en) *	1991-05-24	2007-05-29	Isis Pharmaceuticals, Inc.	Peptide nucleic acid conjugates
JPH06509075A (ja)	1991-07-01	1994-10-13	ユニヴァーシティ　テクノロジーズ　インターナショナル　インコーポレイテッド	ＧｎＲＨ及び他の生物学的に活性なリガンドの非感度低下性類縁体
JP3480848B2 (ja) *	1992-06-19	2003-12-22	タカラバイオ株式会社	環状ペプチドの合成方法
US5569741A (en) *	1992-07-27	1996-10-29	Biomeasure, Inc.	Cyclic octapeptide neuromedin B receptor antagonists
HU224350B1 (hu)	1993-08-09	2005-08-29	Société de Conseils de Recherches et d'ApplicationScientifiques, S.A.S. Á	Gyógyhatású peptidszármazékok
HU221092B1 (en) *	1993-12-23	2002-08-28	Novo Nordisk As	Compounds with growth hormone releasing properties
GB9402767D0 (en)	1994-02-14	1994-04-06	Sandoz Ltd	Improvements in or relating to organic compounds
US5696230A (en) *	1994-08-31	1997-12-09	The Board Of Regents Of The University Of Nebraska	High-affinity response-selective C-terminal analogs of C5a anaphylatoxin
US5750499A (en) *	1995-10-18	1998-05-12	The Salk Institute For Biological Studies	Receptor-selective somatostatin analogs
US5846934A (en) *	1996-02-20	1998-12-08	American Cyanamid Company	Pure somatostatin antagonist and methods of use thereof
US6355613B1 (en) *	1996-07-31	2002-03-12	Peptor Limited	Conformationally constrained backbone cyclized somatostatin analogs
AU3215597A (en)	1996-08-30	1998-03-19	Biomeasure Incorporated	Method of inhibiting fibrosis with a somatostatin agonist
WO1998010786A2 (en) *	1996-09-12	1998-03-19	Yarom Cohen	Pharmaceutical composition for the treatment of syndrome x of reaven
IL130166A0 (en) *	1996-12-04	2000-06-01	Sod Conseils Rech Applic	Somatostatin antagonists
US6887470B1 (en) *	1999-09-10	2005-05-03	Conjuchem, Inc.	Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
DE60232203D1 (de) *	2001-03-06	2009-06-10	Il Consorzio Ferrara Richerche	Verfahren zur Modulation der Proliferation von Schilddrüsenkrebszellen
RU2263678C2 (ru)	2001-03-08	2005-11-10	Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд	Антагонисты соматостатина
JP2004531520A (ja)	2001-04-09	2004-10-14	ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド	ソマトスタチンアゴニスト

2002
- 2002-03-05 RU RU2003129807/04A patent/RU2263678C2/ru not_active IP Right Cessation
- 2002-03-05 HU HU0401535A patent/HUP0401535A3/hu unknown
- 2002-03-05 AU AU2002258465A patent/AU2002258465B2/en not_active Ceased
- 2002-03-05 DE DE60226419T patent/DE60226419D1/de not_active Expired - Lifetime
- 2002-03-05 WO PCT/US2002/006676 patent/WO2002072602A2/en not_active Ceased
- 2002-03-05 EP EP02728410A patent/EP1372688B1/de not_active Expired - Lifetime
- 2002-03-05 PL PL02362838A patent/PL362838A1/xx not_active Application Discontinuation
- 2002-03-05 ES ES02728410T patent/ES2306766T3/es not_active Expired - Lifetime
- 2002-03-05 AT AT02728410T patent/ATE394114T1/de not_active IP Right Cessation
- 2002-03-05 CA CA002439498A patent/CA2439498A1/en not_active Abandoned
- 2002-03-05 RU RU2005117614/04A patent/RU2328504C2/ru not_active IP Right Cessation
- 2002-03-05 CZ CZ20032281A patent/CZ299362B6/cs not_active IP Right Cessation
- 2002-03-05 DK DK02728410T patent/DK1372688T3/da active
- 2002-03-05 US US10/469,836 patent/US7378488B2/en not_active Expired - Lifetime
- 2002-03-05 JP JP2002571515A patent/JP4204322B2/ja not_active Expired - Fee Related
- 2002-03-07 AR ARP020100831A patent/AR035942A1/es not_active Application Discontinuation
2003
- 2003-09-04 NO NO20033911A patent/NO20033911L/no not_active Application Discontinuation
2006
- 2006-07-05 JP JP2006185373A patent/JP2006342171A/ja active Pending
2007
- 2007-08-20 US US11/894,231 patent/US7408024B2/en not_active Expired - Lifetime
2008
- 2008-03-11 US US12/075,319 patent/US20080171853A1/en not_active Abandoned
- 2008-05-12 JP JP2008124961A patent/JP2008255120A/ja active Pending

Also Published As

Publication number	Publication date
CZ299362B6 (cs)	2008-07-02
JP2006342171A (ja)	2006-12-21
JP2004532824A (ja)	2004-10-28
WO2002072602A2 (en)	2002-09-19
HUP0401535A3 (en)	2009-07-28
JP4204322B2 (ja)	2009-01-07
HUP0401535A2 (hu)	2004-12-28
DK1372688T3 (da)	2008-08-25
PL362838A1 (en)	2004-11-02
US20040181032A1 (en)	2004-09-16
RU2005117614A (ru)	2006-11-20
JP2008255120A (ja)	2008-10-23
WO2002072602A3 (en)	2003-03-20
NO20033911D0 (no)	2003-09-04
RU2328504C2 (ru)	2008-07-10
EP1372688A4 (de)	2006-06-14
ES2306766T3 (es)	2008-11-16
AR035942A1 (es)	2004-07-28
CA2439498A1 (en)	2002-09-19
RU2003129807A (ru)	2005-03-20
RU2263678C2 (ru)	2005-11-10
US7408024B2 (en)	2008-08-05
AU2002258465B2 (en)	2006-01-19
US20080020970A1 (en)	2008-01-24
US7378488B2 (en)	2008-05-27
NO20033911L (no)	2003-10-29
EP1372688A2 (de)	2004-01-02
EP1372688B1 (de)	2008-05-07
DE60226419D1 (de)	2008-06-19
CZ20032281A3 (cs)	2004-01-14
US20080171853A1 (en)	2008-07-17

Legal Events

Date

Code

Title

Description

2008-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1372688

Country of ref document: EP

2010-06-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60227853D1 (de)	2008-09-04	Substituierte Pyridinylamine
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
NO20034497L (no)	2003-10-27	Somatostatin agonister
NO20014597D0 (no)	2001-09-21	Fremgangsmåte
ATE374183T1 (de)	2007-10-15	Nk1-antagonisten
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
DK1372688T3 (da)	2008-08-25	Somatostatin-antagonister
DE50213651D1 (de)	2009-08-13	Substituierte 4-aminocyclohexanole
DE50201862D1 (de)	2005-01-27	Messwandler
DE50214673D1 (de)	2010-11-04	Schnittstelle
DE50212426D1 (de)	2008-08-14	Bohrwerkzeug
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
PL362793A1 (pl)	2004-11-02	Antagoniści reseptorów histaminowych
DE50202088D1 (de)	2005-03-03	Garmodulsystem
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
DE50108381D1 (de)	2006-01-19	Synchronisierschaltungsanordnung
DE10295006D2 (de)	2004-10-07	Bauwerksabdichtung
DE60216967D1 (de)	2007-02-01	Substituierte cyclohexanderivate
ATE405973T1 (de)	2008-09-15	Steckverbindung
ATA2892002A (de)	2005-08-15	Beschlag
ATE345337T1 (de)	2006-12-15	Delta1 -pyrroline